People · Operator
Named in public records as an officer, director or promoter · active 2007–2021 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Logical Therapeutics Inc | — | Biotechnology | Series B | $42.5M | $396.9M | 2007 |
| Quoin Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $2.7M | $52.0M | 2021 |
PETER LANKAU at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside PETER LANKAU on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dennis Langer | 1 | 9 |
| Lutz Giebel | 1 | 6 |
| Michael Meyers | 1 | 5 |
| Bryant Fong | 1 | 5 |
| Paul Schmitt | 1 | 5 |
| Martin Edwards | 1 | 5 |
| Dennis H. Langer | 1 | 3 |
| Denise Carter | 1 | 2 |
| Natalie Leong | 1 | 2 |
| CAROLYN GREEN | 1 | 2 |
| PETER H. LANKAU | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.